A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids
NCT ID: NCT02580578
Last Updated: 2020-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2015-07-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Centered Results for Uterine Fibroids
NCT02260752
Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management
NCT05741671
Therapeutic MRI Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids
NCT01141062
Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids
NCT00837161
Fibroid Ablation Study - Large Fibroids
NCT01539187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All Participants
Female patients who are diagnosed and treated for symptoms associated with their uterine fibroids per routine clinical practice. No intervention is administered in this study.
No Intervention
No intervention is administered in this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
No intervention is administered in this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carmen Enciu
Role: STUDY_DIRECTOR
Allergan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peter Lougheed Centre/University of Calgary
Calgary, Alberta, Canada
Urestky Edmonton Clinic
Edmonton, Alberta, Canada
Sanders Vancouver Clinic
Vancouver, British Columbia, Canada
Children's and Women's Health Centre of British Columbia - The University of British Columbia
Vancouver, British Columbia, Canada
Southern Health Centre
White Rock, British Columbia, Canada
Landau Fredericton Clinic
Fredericton, New Brunswick, Canada
Strand Clinic
St. John's, Newfoundland and Labrador, Canada
IWK Healtch Centre
Halifax, Nova Scotia, Canada
Hamilton Health Sciences
Hamilton, Ontario, Canada
Minimally Invasive Gynecology Clinic
London, Ontario, Canada
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
St. Micheals Hospital
Toronto, Ontario, Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
South Windsor Women's Health
Windsor, Ontario, Canada
Centre Gynécologie et Maternité
LaSalle, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Clinique de Gynécologie & Obstétrique Pierre Boucher
Montreal, Quebec, Canada
Complexe Medical Saint-Laurent
Saint-Laurent, Quebec, Canada
University of Saskatchewan
Regina, Saskatchewan, Canada
CHU de Québec-Universite Laval
Québec, , Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bougie O, Bedaiwy MA, Laberge P, Lebovic G, Leyland N, Atri M, Murji A; CAPTURE Steering Committee. Quality of ultrasonography reporting and factors associated with selection of imaging modality for uterine fibroids in Canada: results from a prospective cohort registry. CMAJ Open. 2020 Aug 12;8(3):E506-E513. doi: 10.9778/cmajo.20200004. Print 2020 Jul-Sep.
Bedaiwy MA, Janiszewski P, Singh SS; CAPTURE Steering Committee. A Patient Registry for the Management of Uterine Fibroids in Canada: Protocol for a Multicenter, Prospective, Noninterventional Study. JMIR Res Protoc. 2018 Nov 20;7(11):e10926. doi: 10.2196/10926.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMO-CAN-WH-0412
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.